Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEFINITY in cardiac disease imaging
NCT03719612Phase 3Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Dec 2018
- Primary completion
- Jan 2020
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perflutren lipid microspheres in heart disease, sponsored by Lantheus Holdings, Inc.. Started Dec 2018; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
heart disease
Beyond the preview
Go deeper on NCT03719612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03719612.